- Home
- UTMD vs LRMR Comparison
UTMD vs LRMR Comparison
Compare UTMD & LRMR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- UTMD
- LRMR
- Stock Information
- Founded
- UTMD 1978
- LRMR N/A
- Country
- UTMD United States
- LRMR United States
- Employees
- UTMD N/A
- LRMR N/A
- Industry
- UTMD Medical/Dental Instruments
- LRMR Biotechnology: Pharmaceutical Preparations
- Sector
- UTMD Health Care
- LRMR Health Care
- Exchange
- UTMD Nasdaq
- LRMR Nasdaq
- Market Cap
- UTMD 173.6M
- LRMR 183.8M
- IPO Year
- UTMD N/A
- LRMR N/A
- Fundamental
- Price
- UTMD $52.30
- LRMR $1.91
- Analyst Decision
- UTMD
- LRMR Strong Buy
- Analyst Count
- UTMD 0
- LRMR 9
- Target Price
- UTMD N/A
- LRMR $19.00
- AVG Volume (30 Days)
- UTMD 19.8K
- LRMR 1.0M
- Earning Date
- UTMD 04-28-2025
- LRMR 05-08-2025
- Dividend Yield
- UTMD 2.33%
- LRMR N/A
- EPS Growth
- UTMD N/A
- LRMR N/A
- EPS
- UTMD 3.96
- LRMR N/A
- Revenue
- UTMD $40,903,000.00
- LRMR N/A
- Revenue This Year
- UTMD N/A
- LRMR N/A
- Revenue Next Year
- UTMD N/A
- LRMR N/A
- P/E Ratio
- UTMD $13.21
- LRMR N/A
- Revenue Growth
- UTMD N/A
- LRMR N/A
- 52 Week Low
- UTMD $52.45
- LRMR $1.61
- 52 Week High
- UTMD $77.33
- LRMR $11.20
- Technical
- Relative Strength Index (RSI)
- UTMD 24.05
- LRMR 39.39
- Support Level
- UTMD $52.45
- LRMR $1.76
- Resistance Level
- UTMD $54.80
- LRMR $1.91
- Average True Range (ATR)
- UTMD 1.57
- LRMR 0.17
- MACD
- UTMD -0.15
- LRMR 0.03
- Stochastic Oscillator
- UTMD 0.60
- LRMR 46.15
About UTMD Utah Medical Products Inc.
Utah Medical Products Inc is involved in the business of developing, manufacturing, and distributing medical devices that are mainly proprietary, disposable, and for hospital use. The firm produces its products for Blood pressure monitoring, Blood collection, Electrosurgery, Gynecology, Neonatal critical care, perinatology, and Urology. The company's product portfolio includes Electrosurgical pens, Tenacula, Endoscopic bulb irrigators, and Blood bag spikes. Its products are used mainly in critical care areas, labor and delivery departments of hospitals, and outpatient clinics and physicians' offices.
About LRMR Larimar Therapeutics Inc.
Larimar Therapeutics Inc is a clinical-stage biotechnology company focused on developing treatments for patients suffering from complex rare diseases using novel cell-penetrating peptide technology platform. Its lead product candidate, CTI-1601, is a subcutaneously administered, recombinant fusion protein intended to deliver human frataxin (FXN) an essential protein, to the mitochondria of patients with Friedreich's ataxia.